RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System

Molecular Therapy - Tập 14 Số 4 - Trang 476-484 - 2006
Kenneth A. Howard1,2, Ulrik L. Rahbek1,2, Xiudong Liu1,2, Christian Kroun Damgaard1,2, Sys Zoffmann Glud1,2, Morten Østergaard Andersen1,2, Mads Bruun Hovgaard2, Alexander Schmitz1, Jens R. Nyengaard3, Flemming Besenbacher2,3, Jørgen Kjems1,2
1Department of Molecular Biology, University of Aarhus, 8000 Aarhus C, Denmark
2Interdisciplinary Nanoscience Center (iNANO), University of Aarhus, 8000 Aarhus C, Denmark
3Stereology and Electron Microscopy Research Laboratory, University of Aarhus, 8000 Aarhus C, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Lieberman, 2003, Interfering with disease: opportunities and roadblocks to harnessing RNA interference, Trends Mol. Med., 9, 397, 10.1016/S1471-4914(03)00143-6

Tuschl, 2001, RNA interference and small interfering RNAs, Chembiochemistry, 2, 239, 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.0.CO;2-R

Song, 2003, Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages, J. Virol., 77, 7174, 10.1128/JVI.77.13.7174-7181.2003

Yano, 2004, Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer, Clin. Cancer Res., 10, 7721, 10.1158/1078-0432.CCR-04-1049

Flynn, 2004, Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo, J. Inflammation (London), 1, 4, 10.1186/1476-9255-1-4

Lewis, 2002, Efficient delivery of siRNA for inhibition of gene expression in postnatal mice, Nat. Genet., 32, 107, 10.1038/ng944

Mccaffrey, 2002, RNA interference in adult mice, Nature, 418, 38, 10.1038/418038a

Kobayashi, 2004, Vector-based in vivo RNA interference: dose- and time-dependent suppression of transgene expression, J. Pharmacol. Exp. Ther., 308, 688, 10.1124/jpet.103.059931

Layzer, 2004, In vivo activity of nuclease-resistant siRNAs, RNA, 10, 766, 10.1261/rna.5239604

Lewis, 2005, Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection, Methods Enzymol., 392, 336, 10.1016/S0076-6879(04)92020-4

Schiffelers, 2004, Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle, Nucleic Acids Res., 32, e149, 10.1093/nar/gnh140

Thomas, 2005, Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung, Proc. Natl. Acad. Sci. USA, 102, 5679, 10.1073/pnas.0502067102

Takahashi, 2005, Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases, J. Controlled Release, 105, 332, 10.1016/j.jconrel.2005.04.012

Sioud, 2003, Cationic liposome-mediated delivery of siRNAs in adult mice, Biochem. Biophys. Res. Commun., 312, 1220, 10.1016/j.bbrc.2003.11.057

Sorensen, 2003, Gene silencing by systemic delivery of synthetic siRNAs in adult mice, J. Mol. Biol., 327, 761, 10.1016/S0022-2836(03)00181-5

Urban-Klein, 2005, RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo, Gene Ther., 12, 461, 10.1038/sj.gt.3302425

Nishida, 1991, Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver, Pharm. Res., 8, 437, 10.1023/A:1015886708598

Illum, 2003, Nasal drug delivery—Possibilities, problems and solutions, J. Controlled Release, 87, 187, 10.1016/S0168-3659(02)00363-2

Koping-Hoggard, 2001, Chitosan as a nonviral gene delivery system: structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo, Gene Ther., 8, 1108, 10.1038/sj.gt.3301492

Iqbal, 2003, Nasal delivery of chitosan–DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice, Vaccine, 21, 1478, 10.1016/S0264-410X(02)00662-X

Richardson, 1999, Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA, Int. J. Pharm., 178, 231, 10.1016/S0378-5173(98)00378-0

Okabe, 1997, ‘Green mice' as a source of ubiquitous green cells, FEBS Lett., 407, 313, 10.1016/S0014-5793(97)00313-X

Vinogradov, 1998, Self-assembly of polyamine–poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides, Bioconjugate Chem., 9, 805, 10.1021/bc980048q

Huang, 2005, Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation, J. Controlled Release, 106, 391, 10.1016/j.jconrel.2005.05.004

Ishii, 2001, Mechanism of cell transfection with plasmid/chitosan complexes, Biochim. Biophys. Acta, 1514, 51, 10.1016/S0005-2736(01)00362-5

Barton, 2002, Retroviral delivery of small interfering RNA into primary cells, Proc. Natl. Acad. Sci. USA, 99, 14943, 10.1073/pnas.242594499

Mori, 2005, Mechanism of macrophage activation by chitin derivatives, J. Vet. Med. Sci., 67, 51, 10.1292/jvms.67.51

Feng, 2004, Receptor-mediated stimulatory effect of oligochitosan in macrophages, Biochem. Biophys. Res. Commun., 317, 414, 10.1016/j.bbrc.2004.03.048

Massaro, 2004, Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice, Am. J. Physiol. Lung Cell Mol. Physiol., 287, L1066, 10.1152/ajplung.00067.2004

Koping-Hoggard, 2005, A miniaturized nebulization catheter for improved gene delivery to the mouse lung, J. Gene Med., 7, 1215, 10.1002/jgm.762